Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shanghai STAR Exchange Biologic and Medicine Index Launches May 9

publication date: Apr 22, 2022

The Shanghai STAR Market Biology and Medicine Index, a weighted average of the 50 largest life science companies listed on Shanghai’s STAR Market, will begin operations on May 9. The index is run jointly by the Shanghai Stock Exchange and the China Securities Index Co. Members of the index will include biopharmaceutical, biomedical engineering, biotech agriculture, biomass energy and other companies. Established in 2019, the STAR Market provides a China home for tech companies to IPO and offers competition to Hong Kong’s pre-revenue rules for biopharma IPOs. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital